These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 18502411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, Frassoni F, Locatelli F.
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH, Li XY, Ding J, Jia JF, Zhu P.
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
    Hilchey SP, Bernstein SH.
    Immunol Invest; 2007 Jan; 36(5-6):629-48. PubMed ID: 18161522
    [Abstract] [Full Text] [Related]

  • 7. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
    Bocelli-Tyndall C, Bracci L, Schaeren S, Feder-Mengus C, Barbero A, Tyndall A, Spagnoli GC.
    Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.
    Groh ME, Maitra B, Szekely E, Koç ON.
    Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A.
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes.
    Le Blanc K, Rasmusson I, Götherström C, Seidel C, Sundberg B, Sundin M, Rosendahl K, Tammik C, Ringdén O.
    Scand J Immunol; 2004 Sep; 60(3):307-15. PubMed ID: 15320889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.
    Nasef A, Mazurier C, Bouchet S, François S, Chapel A, Thierry D, Gorin NC, Fouillard L.
    Cell Immunol; 2008 Sep; 253(1-2):16-22. PubMed ID: 18639869
    [Abstract] [Full Text] [Related]

  • 18. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, Shen B, Yin S, Liu W, Cui L, Li N.
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [Abstract] [Full Text] [Related]

  • 19. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
    Bacigalupo A, Valle M, Podestà M, Pitto A, Zocchi E, De Flora A, Pozzi S, Luchetti S, Frassoni F, Van Lint MT, Piaggio G.
    Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, Shi Y.
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.